Aurora Cannabis (TSX:ACB) Research & Development: C$4.0 Mil (TTM As of Mar. 2026)


TSX:ACB Aurora Cannabis Inc TSX:ACB
49 GF Score
Price C$4.05
GF Value C$5.99
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Aurora Cannabis Research & Development?

Aurora Cannabis TSX:ACB +3.05% 49 Research & Development is C$4.0 Mil as of Mar. 2026. GuruFocus rates TSX:ACB with a GF Score™ of 49/100 and a GF Value™ of C$5.99 (Possible Value Trap). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aurora Cannabis's Research & Development for the three months ended in Mar. 2026 was C$1.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was C$4.0 Mil.

Aurora Cannabis  (TSX:ACB) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aurora Cannabis Research & Development Related Terms

Aurora Cannabis Research & Development Historical Data

* Premium members only.

The historical data trend for Aurora Cannabis's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Cannabis Research & Development Chart

Aurora Cannabis Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.45 10.39 3.57 3.68 4.02

Aurora Cannabis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.83 0.90 1.30 0.99
TSX:ACB
49GF Score
Aurora Cannabis Inc TSX:ACB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Cannabis Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$4.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$4.0 Mil mean?
Aurora Cannabis (TSX:ACB) has a Research & Development of C$4.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Aurora Cannabis and its competitors.
Is Aurora Cannabis' Research & Development too high?
Aurora Cannabis' current Research & Development is C$4.0 Mil. Overall, Aurora Cannabis has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Cannabis' Research & Development compare to ZTS?
Aurora Cannabis' Research & Development of C$4.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aurora Cannabis and its competitors. Aurora Cannabis's current Research & Development is C$4.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Aurora Cannabis (TSX:ACB) is currently considered Possible Value Trap. The stock's GF Value™ is C$5.99, compared to a current price of C$4.05 — trading 32.4% below its estimated fair value. The current Research & Development is C$4.0 Mil. Aurora Cannabis' overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aurora Cannabis (TSX:ACB), the current Research & Development is C$4.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Cannabis (TSX:ACB) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued. The current stock price of C$4.05 is trading 32.4% below its estimated GF Value™ of C$5.99. GuruFocus considers Aurora Cannabis to be Possible Value Trap.

Key valuation signals for TSX:ACB:

  • Research & Development: C$4.0 Mil
  • GF Value™: C$5.99 vs. price of C$4.05 (32.4% below fair value)
  • GF Score™: 49/100 with 2 warning signs

No single metric tells the full story. See the TSX:ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Cannabis Business Description

Address 90B Street SW, Suite 2207, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
49GF Score

Get the complete analysis for TSX:ACB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$4.05
Price
C$5.99
GF Value